[ad_1]
Pfizer and BioNTech have approved the coronavirus vaccine for emergency use in the United States.
According to the Food and Drug Administration (FDA) website, the US Centers for Disease Control and Prevention can meet their plans to distribute the vaccine in a timely manner.
Therefore, the mass vaccination of Americans against COVID-19 will soon begin.
As OBOZREVATEL reported, the UK became the first country in the world to adopt a coronavirus vaccine from the German pharmaceutical company BioNTech and its American partner Pfizer for widespread use.
Canada also approved the COVID-19 vaccine from Pfizer and BioNTech, rated it safe, and allowed its use in the country.
Ukraine has equipment for storing coronavirus vaccines produced by Pfizer and BioNTech at a temperature of -70 degrees, but their volume is limited to 100,000 doses.
Meanwhile, Pfizer and Moderna have begun testing their COVID-19 vaccines in children ages 12 to 18.
In clinical trials of the drug from Pfizer and BioNTech, six volunteers died. Two participants received the actual vaccine, the other four received a placebo.
In Great Britain, two employees of the National Health Service (NHS) developed an allergic reaction to the vaccine.
